Location History:
- Tsukuba, JP (2008 - 2011)
- Singapore, SG (2012)
Company Filing History:
2 out of 47 
1 out of 4,770 
1 out of 2,405 
Years Active: 2008-2012
Title: Jun Kusunoki: Innovator in Genetic Modification and Therapeutic Compounds
Introduction
Jun Kusunoki is a notable inventor based in Tsukuba, Japan. He has made significant contributions to the field of genetic modification and therapeutic agents, holding a total of 3 patents. His work focuses on understanding and manipulating genetic functions to address various health issues.
Latest Patents
One of Kusunoki's latest patents involves the creation of a gene-modified non-human animal with an inactivated MGAT2 gene. This invention aims to facilitate the search for the function of MGAT2 in vivo. Additionally, it provides methods for screening compounds that can inhibit the activity of MGAT2, which is crucial for detecting diseases induced by abnormal lipid metabolism. Another significant patent pertains to spirochromanone derivatives, which serve as acetyl coenzyme A carboxylase (ACC) inhibitors. This compound is useful as a therapeutic agent for various ACC-related disorders.
Career Highlights
Throughout his career, Jun Kusunoki has worked with prominent companies such as MSD K.K. and Merck & Company, Inc. His experience in these organizations has contributed to his expertise in the field of genetic research and therapeutic development.
Collaborations
Kusunoki has collaborated with notable individuals in his field, including Takeru Yamakawa and Hideki Jona. These partnerships have likely enhanced his research and innovation efforts.
Conclusion
Jun Kusunoki's work in genetic modification and therapeutic compounds showcases his commitment to advancing medical science. His patents reflect a deep understanding of genetic functions and their implications for health, making him a significant figure in his field.